Save information for later
Sign Up

Learn About Blepharophimosis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Blepharophimosis Local Doctors?
Elite in Blepharophimosis
Elite in Blepharophimosis
Gent, VLG, BE 

Elfride De Baere practices in Gent, Belgium. De Baere is rated as an Elite expert by MediFind in the treatment of Blepharophimosis. Their top areas of expertise are Blepharophimosis, Leber Congenital Amaurosis, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Elite in Blepharophimosis
Elite in Blepharophimosis
Gent, VLG, BE 

Hannah Verdin practices in Gent, Belgium. Ms. Verdin is rated as an Elite expert by MediFind in the treatment of Blepharophimosis. Her top areas of expertise are Blepharophimosis, Congenital Microcoria, Retinopathy Pigmentary Mental Retardation, Vitrectomy, and Cataract Removal.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Blepharophimosis
Medical Genetics | Pediatrics
Experienced in Blepharophimosis
Medical Genetics | Pediatrics

Florida Hospital Medical Group Inc

2600 Westhall Ln, 
Maitland, FL 
Languages Spoken:
English, Japanese
Accepting New Patients
Offers Telehealth

Mari Mori is a Medical Genetics specialist and a Pediatrics provider in Maitland, Florida. Dr. Mori is rated as an Experienced provider by MediFind in the treatment of Blepharophimosis. Her top areas of expertise are Glycogen Storage Disease Type 7, FG Syndrome, Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Von Gierke Disease. Dr. Mori is currently accepting new patients.

What are the latest Blepharophimosis Clinical Trials?
A Randomised, Double-Masked, Placebo-Controlled Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops) Used Twice Daily (BID) in the Treatment of Acquired Blepharoptosis

Summary: A Randomised, Double-Masked, Placebo-Controlled Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops) used twice daily (BID) in the Treatment of Acquired Blepharoptosis

Match to trials
Find the right clinical trials for you in under a minute
Get started